Background {#s1}
==========

In 2016, there were an estimated 10.4 million incident cases of TB (range, 8.8 million to 12.2 million) \[[@R01]\]. The estimated global burden of MDR-TB is 500 000 patients and approximately half of MDR-TB new cases are found in China, India and Russia \[[@R02]\]. Peru accounts for 14% TB patients and 35% of MDR patients in America \[[@R03]\]. Different studies indicate that mutations in rpoB, inhA, katG, gyrA and rrs MTB genes confer drug resistance to rifampicin (RIF), isoniazid (INH), fluoroquinolone (FLQ) and aminoglycosides (AMG), respectively \[[@R04]\]. In MDR-TB, bacterium is resistant to the main two first-line antibiotics (INH and RIF). rpoB mutations are restricted to an 81bp hot spot region resulting in amino acid substitutions responsible for a minimum of 95% resistance to RIF \[[@R05]\]. inhA and katG mutations correspond to 20% and 70% of INH resistance, respectively. XDR-TB causes drug resistance to RIF, INH, FLQ and at least one of the aminoglycosides such as capreomycin (CAP), kanamycin (KAN) or amikacin (AMK) \[[@R06]\]. gyrA mutations account for more than 90% of drug resistance to FLQs. Mutations in rrs gene correlate phenotypically with high levels of resistance to KAN, AMK and CAP \[[@R06]\] in specific regions.

Several methods are available to detect drug resistance in TB. These include RFLP-PCR \[[@R07]\], multi-allele specific PCR \[[@R08]\], realtime PCR by high resolution melting (PCR-HRM) \[[@R09]\], and GenoType MTBDRplus \[[@R10]\]. However, these methods have shown limited application in low-resource settings due to host cost with specialized equipment and trained staff \[[@R07], [@R10]\]. Therefore, there is a need for a fast, efficient and easy to implement method. It is of interest to identify antibiotic resistant bacteria by mismatch mutation detections in gene fragments associated to drug resistance in MTB samples.

Methodology {#s2}
===========

We used DNAs isolated from MTB culture samples. Samples were confirmed for their drug-resistance using drug susceptibility testing (DST) for first- and second-line anti-tuberculosis drugs using agar proportion method \[[@R04]\]. The five steps used in sample processing are outlined below.

Genomic DNA extraction {#s2a}
----------------------

Sixteen microbial DNA samples were extracted using the PureLink™ Genomic DNA kit (ThermoFisher Scientific, USA), using the procedure described by the manufacturer.

Primer design {#s2b}
-------------

PCR primers were designed for each target region (Table 1) using Primer 3 software \[[@R11]\]for amplification of polymorphic regions in rpoB, inhA, katG, gyrA and rrs genes.

DNA fragments amplification {#s2c}
---------------------------

Polymorphic regions that have been associated to drug resistance in each gene were selected using known literature \[[@R07], [@R12]\]. Five regions were amplified by PCR: DNA-rpoB, DNA-inhA, DNAKatG, DNA-gyrA and DNA-rrs in each one of 15 DNA samples.

Hybridization with DNA reference {#s2d}
--------------------------------

PCR fragments of five genes (rpoB, inhA, katG, gyrA and rrs) from M. tuberculosis H37Rv (pan susceptible laboratory strain) was used to hybridize with PCR products obtained from the samples. The hybridization between DNA wildtype (H37Rv) and DNA mutant generated a hetero-duplex DNA. Hetero-duplex DNA was digested using Detection Enzyme of GeneArt Genomic Cleavage Detection Kit (ThermoFisher Scientific, USA), using the procedure described by the manufacturer. The enzyme recognizes the presence of mismatch. The cleaved DNA heteroduplex generated different DNA fragments size according to position mutation.

Fragment analysis {#s2e}
-----------------

Different band sizes of genes associated with drug resistance were visualized by agarose gel electrophoresis using a gel documentation system (Chemidoc XRS, Biorad, USA).

Results & Discussion {#s3}
====================

Amplified fragments of rpoB, katG, gyrA, inhA and rrs genes were obtained using 10 designed primers given in [Table 1](#T1){ref-type="table"}. Gel electrophoresis band size patterns of sensitive M. tuberculosis, MDR and XDR are showed in [Figure 1](#F1){ref-type="fig"}. We show different types of group fragments with positive mutations for drug resistance. In previous studies, fragment amplification was described as a powerful tool \[[@R13], [@R14]\]. We standardized primers and the annealing of PCR fragments with and without indels to form heteroduplex DNA.

We determined the presence of mutations associated with drug resistance according to the presence of different DNA fragment sizes providing a positive diagnosis for drug resistance ([Figure 1](#F1){ref-type="fig"}). Results show that we can determine the presence of mutations revealed in DNA fragments: 400 bp and 288 bp (rpoB), 280 bp (inhA), 310 bp (katG), 461 bp (gyrA) and 427 bp (rrs) ([Table 2](#T2){ref-type="table"}).

There are advantages of mismatch cleavage endonucleaseI compared with other traditional mutation detection methods like single strand conformation polymorphism analysis, denaturing high-performance liquid chromatography, and heteroduplex analysis \[[@R15]\]. There is detection of all types of base substitution and insertion/deletion mismatches; cleavages of the fragments provide information about the location of mutation and multiple cleavage products indicate the presence of more than one variant \[[@R15]\]. According to our study and other\'s experience \[[@R16]\], endonucleaseI is a much better mismatch cleavage enzyme than phage resolvases because the latter produce many nonspecific bands, are size-limited, and additional experience is required for experiment assessment \[[@R17], [@R18], [@R19], [@R20]\]. We demonstrated the utility of GeneArt Genomic Cleavage Detection Kit to detect mismatch in hetero-duplex DNA associated to drug resistance in MTB.

Conclusion {#s4}
==========

We hybridized five DNA fragments from M. tuberculosis samples to detect mutations in genes associated with drug resistance. The technique detects the presence of mutations in DNA fragments in MDR and XDR-TB. This method does not require expensive specialized equipment. It is also is fast, efficient and easy to implement in standard molecular biology laboratories.
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###### Primers designed to amplify rpoB, inhA, katG, gyrA and rrs fragments of Mycobacterium tuberculosis.

  Gene   Primer                                      Sequence (5\' - 3\')                        Size (pb)   Annealing Temp. (°C)
  ------ ------------------------------------------- ------------------------------------------- ----------- ----------------------
  rpoB   1F                                          GGTGCCGGTGGAAACCGACGACA                     650         
  1R     GCCCCCGTCAATTCTAGTCCACCTCAGACGA                                                                     
  rrs    2F                                          TCGTCTGAGGTGGACTAGAATTGACGGGGGC             630         
  2R     CATACGAGCTCTTCTCTAGAAGGTGATCCAGCCGCACCTT                                                            
  katG   3F                                          AAGGTGCGGCTGGATCACCTTCTAGAGAAGAGCTCGTATG    500         60
  3R     ATTGCGCAGCAGGTATGTTCTAGAGACGAGGTCGTGGCTGA                                                           
  inhA   4F                                          TCAGCCACGACCTCGTCTCTAGAACATACCTGCTGCGCAAT   450         
  4R     GGTGGTAGTTGCCCATTCTAGATCACATTCGACGCCAAAC                                                            
  gyrA   5F                                          GTTTGGCGTCGAATGTGATCTAGAATGGGCAACTACCACC    550         
  5R     CTTCTACCTCAACAACTCCGCGC                                                                             

###### Mismatch-specific DNA frangment sizes for drug resistance bacterium by electrophoresis gel analysis using Chemidoc XRS Software (Biorad, USA).

  Gene   Fragment sizes (bp)
  ------ ---------------------
  rpoB   400 - 288
  inhA   280
  katG   310
  gyrA   461 - (360 in XDR)
  rrs    427 - (330 in MDR)

![Five genetic fragments hybridization related to genotypic resistance to antituberculosis drugs using mismatch-specific DNA. Ladder: molecular weight marker (Kapa DNA ladder). Note: -\> Fragments only in drug resistance bacteria.](97320630014404F1){#F1}
